009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
Business Of Biotech
00:00
The Evolution of the CMC Package at Bolt Bio
As you progress through the clinical stages of then onto the market, there's a lot of evolution. It comes down to two or three main points. You learn a lot more about your drug and the manufacturing processes associated with that drug. And finally, as the advancement through clinic progresses, you really understand what is the right way to deliver the drug to the patient who needs it.
Play episode from 25:05
Transcript
